Screener
Praxis Precision Medicines, Inc. PRAX Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: Praxis Precision Medicines, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001689548-26-000083
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Accrued expenses | (10,446) | (4,806) |
| Operating lease liabilities | (449) | (614) |
| Other | (643) | (3) |
| Net cash used in operating activities | (163,694) | (107,686) |
| Cash flows from investing activities: | ||
| Capitalized internal-use software costs | (773) | — |
| Purchases of property and equipment | (307) | (56) |
| Purchases of marketable securities | (564,050) | (158,404) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Praxis Precision Medicines, Inc.'s operating cash flow?
- Praxis Precision Medicines, Inc. (PRAX) reported operating cash flow of -$77.54M in Q2 2026.
- How has Praxis Precision Medicines, Inc.'s operating cash flow changed year-over-year?
- Praxis Precision Medicines, Inc.'s operating cash flow decreased by 41.8% year-over-year, from -$54.68M to -$77.54M.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s operating cash flow?
- Over 4 years (2021 to 2025), Praxis Precision Medicines, Inc.'s operating cash flow has grown at a 18.9% compound annual growth rate (CAGR), from -$124.55M to -$249.07M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about Praxis Precision Medicines, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude